CAR T manufacturing

CAR T manufacturing

featured image of MilliporeSigma's €300 Million Investment Fuels South Korea's Bioproduction Boom

MilliporeSigma’s €300 Million Investment Fuels South Korea’s Bioproduction Boom

BIOT

📢 MilliporeSigma invests €300 million in South Korea bioproduction site, creating 300 jobs and supporting biotech and pharma industries. 🏭💼🧪🧬

featured image of Game-Changing Cancer Immunotherapy Deal Unveiled

Game-Changing Cancer Immunotherapy Deal Unveiled

BIOT

📰 Domain Therapeutics and Chime Biologics join forces to develop an anti-CCR8 antibody for cancer immunotherapy! 👥💉 Exciting times ahead! 🤝

featured image of Boost AAV Genome Production with RevIT Enhancer!

Boost AAV Genome Production with RevIT Enhancer!

BIOT

🚀 Boost AAV genome production with RevIT™ AAV Enhancer! 🧬💰 Increase titers, streamline workflows, and save costs in gene therapy manufacturing.

featured image of Revolutionary Partnership Expands Cell Therapy Development

Revolutionary Partnership Expands Cell Therapy Development

BIOT

📰 Multiply Labs and Thermo Fisher join forces to revolutionize cell therapy production! 💼🔬 Accelerating development and commercialization for patients. 🏭

featured image of AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

AZ Accelerates Cell Therapy Production with FasTCAR: Faster Cheaper and Accessible

BIOT

📢 AstraZeneca teams up with FasTCAR to fast-track cell therapy production, revolutionizing accessibility and affordability for patients. 🚀

featured image of Samsung Biologics and LegoChem unite to revolutionize cancer treatment

Samsung Biologics and LegoChem unite to revolutionize cancer treatment

BIOT

🔍 Samsung Biologics teams up with LegoChem to advance ADCs, combining antibodies and drugs to target cancer cells. 🔬 Collaboration leverages manufacturing expertise and ADC development technology for better cancer treatment options.

featured image of BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments

BioNTech and Autolus Join Forces for Revolutionary Cancer Treatments

BIOT

📢 BioNTech and Autolus join forces in a $250m deal to revolutionize CAR-T cell therapies for cancer treatment. 💼🔬💪

featured image of Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

Game-Changing Novo Catalent Deal Revolutionizes CGT Outsourcing

BIOT

📢 Get ready for a game-changer! The Novo Catalent deal is about to shake up the CGT outsourcing space. 💥🧪💼

featured image of Evotec's Breakthrough: Expanding HIV Antibody Deal

Evotec’s Breakthrough: Expanding HIV Antibody Deal

BIOT

📰 Evotec expands anti-HIV antibody deal with ABL to develop and manufacture neutralizing antibodies against HIV. Just-Evotec Biologics to develop third antibody and provide manufacturing services for Phase I clinical study. Partnership aims to deliver new HIV therapies. 💉🌍

featured image of Regulatory Spotlight on Cleaning Validation in Biotech

Regulatory Spotlight on Cleaning Validation in Biotech

BIOT

📢 Cleaning validation is receiving increased attention from regulatory agencies in the biotechnology industry. 🧪🔬🏭🔍💼🔒